Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity-Reference-Cited by-同舟云学术

Antibody-independent B cell effector functions in relapsing remitting Multiple Sclerosis: Clues to increased inflammatory and reduced regulatory B cell capacity

Published:2012-04-18 Issue:5 Volume:45 Page:400-414
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Ireland Sara J.,Blazek Monica,Harp Christopher T.,Greenberg Benjamin,Frohman Elliot M.,Davis Laurie S.,Monson Nancy L.

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.3109/08916934.2012.665529

Reference131 articles.

1. Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial

2. B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

3. Emerging Therapies in Relapsing-Remitting Multiple Sclerosis

4. Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

5. B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications;Journal of Neurology;2024-04-17

2. Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment;Neurologic Clinics;2024-02

3. Intruders or protectors – the multifaceted role of B cells in CNS disorders;Frontiers in Cellular Neuroscience;2024-01-10

4. Cytokine producing B-cells and their capability to polarize macrophages in giant cell arteritis;Journal of Autoimmunity;2023-11

5. Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets;Pharmaceutics;2023-02-22